Loading organizations...
Loading organizations...
Clinical-stage biopharmaceutical company developing Live Biotherapeutics.
Exeliom has raised $20.5M across 3 funding rounds.
Exeliom has raised $20.5M in total across 3 funding rounds.
Exeliom has raised $20.5M in total across 3 funding rounds.
Exeliom's investors include Jean-Marie Lefevre, Crescent Ventures, Ismail Kola, UI Investissement, Crescent Enterprises, Auriga Partners, Biocodex, Capital Grand Est, INRA, Sofimac Innovation.
Exeliom has raised $20.5M across 3 funding rounds. Most recently, it raised $3.3M Series A Extension in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 21, 2025 | $3.3M Series A Extension | Jean-Marie Lefevre | Crescent Ventures, Ismail Kola, UI Investissement |
| Jul 20, 2023 | $8.9M Series A Extension | Crescent Enterprises | Auriga Partners, Biocodex, Capital Grand Est, UI Investissement |
| Jul 9, 2018 | $8.2M Series A | Auriga Partners | Biocodex, Capital Grand Est, INRA, Sofimac Innovation |